Search results
Results from the WOW.Com Content Network
A Drug Enforcement Administration (DEA) judge canceled an upcoming hearing on the Biden administration’s marijuana rescheduling proposal pending appeals, effectively kicking the process to the ...
On December 17, 2009, Rev. Bryan A. Krumm, CNP, filed a rescheduling petition for Cannabis with the DEA arguing that "because marijuana does not have the abuse potential for placement in Schedule I of the CSA, and because marijuana now has accepted medical use in 13 states, and because the DEA's own Administrative Law Judge has already ...
After the DEA reviews and considers the public comments, and at the conclusion of any requested hearing, the DEA will issue a final order to reschedule marijuana. (The DEA could decline to ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
A nationwide survey last fall commissioned by the Coalition for Cannabis Rescheduling Reform found nearly 60% of likely voters supported rescheduling, with 65% of younger voters 18 to 25 favoring ...
The Federal administrative process that began with President Biden's directive in 2022, and in 2023 with a recommendation by the Department of Health and Human Services to reschedule cannabis to Schedule III of the Controlled Substances Act was incomplete at the beginning of 2024. [1]
The change from Schedule I to Schedule III is welcome, but removing it from the schedules altogether is the best option.
The Biden administration plans to reclassify marijuana for the first time since the Controlled Substances Act was enacted more than 50 years ago.